Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Rhea-AI Summary

Teknova (Nasdaq: TKNO), a producer of critical reagents for therapy, vaccine, and molecular diagnostics development, has scheduled its fourth quarter and full year 2024 financial results announcement for March 4, 2025, after market close. The company will host a webcast and conference call at 5 p.m. Eastern Time on the same day. Investors can access the webcast through Teknova's Investor Relations website section, and participants requiring dial-in information need to register to receive a unique PIN number.

HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2024, on Tuesday, March 4, 2025, following the close of market.

Teknova will host a webcast and conference call on Tuesday, March 4, 2025, beginning at 5 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.

Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100 

Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259

FAQ

When will Teknova (TKNO) release Q4 and full year 2024 earnings?

Teknova (TKNO) will release its Q4 and full year 2024 earnings on March 4, 2025, after market close.

What time is Teknova's (TKNO) Q4 2024 earnings call?

Teknova's Q4 2024 earnings call is scheduled for March 4, 2025, at 5 p.m. Eastern Time.

How can investors access Teknova's (TKNO) Q4 2024 earnings call?

Investors can access Teknova's earnings call through the Investor Relations section of the company's website or by registering for the webcast to receive dial-in information.

Will Teknova's (TKNO) Q4 2024 earnings call be available for replay?

Yes, the earnings call webcast will be available for replay on Teknova's website approximately two hours after the event.